Roman Hovorka
Roman Hovorka
Verified email at
Cited by
Cited by
Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range
T Battelino, T Danne, RM Bergenstal, SA Amiel, R Beck, T Biester, E Bosi, ...
Diabetes care 42 (8), 1593-1603, 2019
International consensus on use of continuous glucose monitoring
T Danne, R Nimri, T Battelino, RM Bergenstal, KL Close, JH DeVries, ...
Diabetes care 40 (12), 1631-1640, 2017
Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes
R Hovorka, V Canonico, LJ Chassin, U Haueter, M Massi-Benedetti, ...
Physiological measurement 25 (4), 905, 2004
Continuous glucose monitoring and closed‐loop systems
R Hovorka
Diabetic medicine 23 (1), 1-12, 2006
Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial
R Hovorka, JM Allen, D Elleri, LJ Chassin, J Harris, D Xing, C Kollman, ...
The Lancet 375 (9716), 743-751, 2010
Home use of an artificial beta cell in type 1 diabetes
H Thabit, M Tauschmann, JM Allen, L Leelarathna, S Hartnell, ...
New England Journal of Medicine 373 (22), 2129-2140, 2015
Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT
R Hovorka, F Shojaee-Moradie, PV Carroll, LJ Chassin, IJ Gowrie, ...
American Journal of Physiology-Endocrinology and Metabolism 282 (5), E992-E1007, 2002
Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis
E Bekiari, K Kitsios, H Thabit, M Tauschmann, E Athanasiadou, ...
bmj 361, 2018
Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
M Tauschmann, H Thabit, L Bally, JM Allen, S Hartnell, ME Wilinska, ...
The Lancet 392 (10155), 1321-1329, 2018
Closed-loop insulin delivery: from bench to clinical practice
R Hovorka
Nature Reviews Endocrinology 7 (7), 385-395, 2011
Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies
R Hovorka, K Kumareswaran, J Harris, JM Allen, D Elleri, D Xing, ...
Bmj 342, 2011
Insulin kinetics in type-1 diabetes: continuous and bolus delivery of rapid acting insulin
ME Wilinska, LJ Chassin, HC Schaller, L Schaupp, TR Pieber, R Hovorka
IEEE Transactions on Biomedical Engineering 52 (1), 3-12, 2004
Simulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetes
ME Wilinska, LJ Chassin, CL Acerini, JM Allen, DB Dunger, R Hovorka
Journal of diabetes science and technology 4 (1), 132-144, 2010
Closed-loop insulin delivery during pregnancy in women with type 1 diabetes
ZA Stewart, ME Wilinska, S Hartnell, RC Temple, G Rayman, KP Stanley, ...
New England Journal of Medicine 375 (7), 644-654, 2016
Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial
R Hovorka, D Elleri, H Thabit, JM Allen, L Leelarathna, R El-Khairi, ...
Diabetes care 37 (5), 1204-1211, 2014
Coming of age: the artificial pancreas for type 1 diabetes
H Thabit, R Hovorka
Diabetologia 59 (9), 1795-1805, 2016
Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive …
J Plank, J Blaha, J Cordingley, ME Wilinska, LJ Chassin, C Morgan, ...
Diabetes care 29 (2), 271-276, 2006
Outcome measures for artificial pancreas clinical trials: a consensus report
DM Maahs, BA Buckingham, JR Castle, A Cinar, ER Damiano, E Dassau, ...
Diabetes care 39 (7), 1175-1179, 2016
Clinical review: consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults
S Finfer, J Wernerman, JC Preiser, T Cass, T Desaive, R Hovorka, ...
Critical Care 17, 1-13, 2013
New closed-loop insulin systems
CK Boughton, R Hovorka
Diabetologia 64, 1007-1015, 2021
The system can't perform the operation now. Try again later.
Articles 1–20